Although this remains speculative, the lack of response in CLL cells originating from patient 8 and 9 could be explained by an initially low AR frequency (patient no. 9) or upregulation of alternative, CDC42-independent actin polymerization pathways (patient no. 8). Here, AR is linked to B-cell chronic lymphocytic leukemia.